Sam Altman Backs $1 Billion Bet to Add a DECADE to Your Life
Retro Biosciences: The $1 Billion Lifespan Revolution
Imagine living 10 years longer—not just alive, but thriving. That’s the audacious mission of Retro Biosciences, a San Francisco biotech startup backed by none other than OpenAI CEO Sam Altman. And they’re not just dreaming—they’re raising a jaw-dropping $1 billion Series A to make it happen.
Altman isn’t new to this game. He’s already poured $180 million into Retro Biosciences’ seed round. Now, he’s doubling down, joining the latest funding round reported by the Financial Times. This isn’t just another tech investment—it’s a moonshot to redefine what it means to age.
What’s the Big Deal?
Retro Biosciences isn’t just tinkering with the idea of longevity—they’re attacking it head-on. Their plan? Develop drugs that target age-related diseases like Alzheimer’s and turn back the clock on aging itself. They’ve even teamed up with OpenAI to train a model that transforms regular cells into stem cells—a breakthrough that could rewrite the rules of human biology.
“We’re moving fast. We want to discover and develop a drug in the 2020s.”
Joe Betts-LaCroix, CEO of Retro Biosciences
The Billionaire Longevity Race
Retro Biosciences isn’t alone in this fight. They’re joining a growing list of billionaire-backed ventures aiming to conquer aging:
- Altos Labs: Launched in 2022 with $3 billion from Jeff Bezos.
- Unity Biotechnology: Backed by both Bezos and Peter Thiel.
This isn’t just science—it’s a high-stakes race to unlock the secrets of human longevity. And with Altman’s backing, Retro Biosciences is sprinting ahead.
Why This Matters
This isn’t just about living longer—it’s about living better. Imagine a world where Alzheimer’s is a thing of the past, where your 80s feel like your 50s, and where aging isn’t a decline but a new frontier. That’s the future Retro Biosciences is building—and they’re doing it with $1 billion and a relentless drive to win.
So, are you ready to add a decade to your life? Because the future of aging is here, and it’s moving faster than ever.
